The Fat in Your Liver and Pancreas: A Double Whammy for Heart and Metabolism
A large study using the UK Biobank reveals that when fat accumulates in both the liver and the pancreas—a condition known as dual-organ steatosis—the risk for developing cardiometabolic multimorbidity (a combination of diabetes, hypertension, coronary heart disease, or stroke) more than doubles. The research, which also included a biopsy-proven cohort from China, found that pancreatic steatosis is linked to more severe liver disease. Furthermore, this dual fat deposition was associated with adverse structural changes in the heart, such as increased left ventricular mass and impaired function. Proteomic analysis suggests that unique molecular pathways, particularly those involved in breaking down heparan sulphate, are activated when both organs are affected.
Why it might matter to you:
This research underscores a systemic link between ectopic fat, metabolic disease, and cardiac health, moving beyond a liver-centric view of MASLD. For clinicians managing diabetes and its complications, it highlights the potential value of assessing pancreatic fat as an additional risk marker for predicting and preventing cardiovascular outcomes in patients with metabolic dysfunction. This could influence screening protocols and encourage a more holistic approach to managing metabolic syndrome.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
